Anti-atherosclerotic action of Ger-Gen-Chyn-Lian-Tang and AMPK-dependent lipid lowering effect in hepatocytes

Journal of Ethnopharmacology

Volumn 142, Issue 1, 2012, Pages 175-187

  Ho, Feng Ming ^a,b   Liao, Yi Hsiang ^c   Yang, Ai Jen ^c   Lee Chao, Pei Dawn ^d   Hou, Yu Chi ^d,e   Huang, Chen Tsung ^c   Lin, Shu Rung ^b   Lee, Kueir Rarn ^b   Huang, Kuo Chin ^f   Lin, Wan Wan ^c,g  

^a TAO YUAN GENERAL HOSPITAL   (Taiwan)

^b CHUNG YUAN CHRISTIAN UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

AMPK; ApoE knockout; Atherosclerosis; GGCLT; PPARs

Indexed keywords

ADENYLATE KINASE; ANTILIPEMIC AGENT; BAICALEIN; BAICALIN; BERBERINE; CHINESE DRUG; CHOLESTEROL; COLLAGEN; COPTISINE; DAIDZEIN; DAIDZIN; GER GEN CHYN LIAN TANG; GLUCOSE; GLYCYRRHIZIC ACID; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; PALMATINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PLANT EXTRACT; PUERARIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; WOGONIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; GLUCOSE BLOOD LEVEL; LIPID BLOOD LEVEL; LIVER CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE; VASCULAR SMOOTH MUSCLE CELL;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; AORTA, THORACIC; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CARDIOTONIC AGENTS; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; DRUGS, CHINESE HERBAL; GLYCYRRHIZA; HEPATOCYTES; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCYTES, SMOOTH MUSCLE; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; RATS; RATS, WISTAR; SCUTELLARIA BAICALENSIS;

MUS; SCUTELLARIA RADIX;

EID: 84861992637     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2012.04.034     Document Type: Article

References (56)

1. Akbiyik, F., Cinar, K., Demirpence, E., Ozsullu, T., Tunca, R., Haziroglu, R., Yurdaydin, C., Uzunalimoglu, O., Bozkaya, H., 2004. Ligand-induced expression of peroxisome proliferator-activated receptor alpha and activation of fatty acid oxidation enzymes in fatty liver. European Journal of Clinical Investigation 34, 429-435.
2. Bronner, M., Hertz, R., Bar-Tana, J., 2004. Kinase-independent transcriptional co-activation of peroxisome proliferator-activated receptor alpha by AMP-activated protein kinase. Biochemistry Journal 384, 295-305.
3. Burns, K.A., Vanden Heuvel, J.P., 2007. Modulation of PPAR activity via phosphorylation. Biochimica et Biophysica Acta 1771, 952-960.
4. Cherdshewasart, W., Sutjit, W., 2008. Correlation of antioxidant activity and major isoflavonoid contents of the phytoestrogen-rich Pueraria mirifica and Pueraria lobata tubers. Phytomedicine 15, 38-43.
5. Chi, Y.S., Lim, H., Park, H., Kim, H.P., 2003. Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochemistry and Pharmacology 66, 1271-1278.
6. Ewart, M.A., Kennedy, S., 2011. AMPK and vasculoprotection. Pharmacology & Therapeutics 131, 242-253.
7. Fisslthaler, B., Fleming, I., 2009. Activation and signaling by the AMP-activated protein kinase in endothelial cells. Circular Research 105, 114-127.
8. Han, Y., Wang, Q., Song, P., Zhu, Y., Zou, M.H., 2010. Redox regulation of the AMP-activated protein kinase. PLoS One 5, e15420.
9. Hardie, D.G., Carling, D., 1997. The AMP-activated protein kinase - fuel gauge of the mammalian cell? European Journal of Biochemistry 246, 259-273.
10. Hirota, K., Morikawa, K., Hanada, H., Nonaka, M., Nakajima, Y., Kobayashi, M., Nakajima, R., 2010. Effect of genistein and daidzein on the proliferation and differentiation of human preadipocyte cell line. Journal of Agricultural and Food Chemistry 58, 5821-5827.
11. Hong, T., Jin, G.B., Cho, S., Cyong, J.C., 2002. Evaluation of the anti-inflammatory effect of baicalein on dextran sulfate sodium-induced colitis in mice. Planta Medica 68, 268-271.
12. Huang, W.H., Lee, A.R., Yang, C.H., 2006. Antioxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI. Bioscience Biotechnology and Biochemistry 70, 2371-2380.
13. 2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases. Journal of Biological Chemistry 280, 29060-29066.
14. Hwang, Y.P., Kim, H.G., Hien, T.T., Jeong, M.H., Jeong, T.C., Jeong, H.G., 2011. Puerarin activates endothelial nitric oxide synthase through estrogen receptor-dependent PI3-kinase and calcium-dependent AMP-activated protein kinase. Toxicology and Applied Pharmacology 257, 48-58.
15. Ibabe, A., Herrero, A., Cajaraville, M.P., 2005. Modulation of peroxisome proliferator-activated receptors (PPARs) by PPAR(alpha)- and PPAR(gamma)-specific ligands and by 17beta-estradiol in isolated zebrafish hepatocytes. Toxicology in Vitro 19, 725-735.
16. Karagiannides, I., Abdou, R., Tzortzopoulou, A., Voshol, P.J., Kypreos, K.E., 2008. Apolipoprotein E predisposes to obesity and related metabolic dysfunctions in mice. FEBS Journal 275, 4796-4809.
17. Kasai, A., Hiramatsu, N., Hayakawa, K., Yao, J., Kitamura, M., 2008. Blockade of the dioxin pathway by herbal medicine formula bupleuri minor: identification of active entities for suppression of AhR activation. Biological and Pharmaceutical Bulletin 31, 838-846.
18. Kim, W.S., Lee, Y.S., Cha, S.H., Jeong, H.W., Choe, S.S., Lee, M.R., Oh, G.T., Park, H.S., Lee, K.U., Lane, M.D., Kim, J.B., 2009a. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. American Journal of Physiological Endocrinology Metabolism 296, E812-E819.
19. Kim, S., Takahashi, H., Lin, W.W., Descargues, P., Grivennikov, S., Kim, Y., Luo, J.L., Karin, M., 2009b. Carcinoma produced factors activate myeloid cells via TLR2 to stimulate metastasis. Nature 457, 102-106.
20. Kim, H.S., Kim, M.J., Kim, E.J., Yang, Y., Lee, M.S., Lim, J.S., 2012. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochemistry and Pharmacology 83, 385-394.
21. LeBrasseur, N.K., Kelly, M., Tsao, T.S., Farmer, S.R., Saha, A.K., Ruderman, N.B., Tomas, E., 2006. Thiazolidinediones can rapidly activate AMP-activated protein kinase in mammalian tissues. American Journal of Physiological Endocrinology Metabolism 291, E175-E181.
22. Lee, W.J., Kim, M., Park, H.S., Kim, H.S., Jeon, M.J., Oh, K.S., Koh, E.H., Won, J.C., Kim, M.S., Oh, G.T., Yoon, M., Lee, K.U., Park, J.Y., 2006a. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1. Biochemical and Biophysical Research Communications 340, 291-295.
23. Lee, Y.S., Kim, W.S., Kim, K.H., Yoon, M.J., Cho, H.J., Shen, Y., Ye, J.M., Lee, C.H., Oh, W.K., Kim, C.T., Hohnen-Behrens, C., Gosby, A., Kraegen, E.W., James, D.E., Kim, J.B., 2006b. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 55, 2256-2264.
24. Lee, J.W., Mase, N., Yonezawa, T., Seo, H.J., Jeon, W.B., Cha, B.Y., Nagai, K., Woo, J.T., 2010. Palmatine attenuates osteoclast differentiation and function through inhibition of receptor activator of nuclear factor-κb ligand expression in osteoblast cells. Biological and Pharmaceutical Bulletin 33, 1733-1739.
25. Lee, J.W., Iwahashi, A., Hasegawa, S.I., Yonezawa, T., Jeon, W.B., Cha, B.Y., Nagai, K., Woo, J.T., Nagai, K., Woo, J.T., 2012. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells. Journal of Nature Medicine 66, 8-16.
26. Leff, T., 2003. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochemical Society Transactions 31, 224-227.
27. Li-Weber, M., 2009. New therapeutic aspects of flavones: the anticancer properties of Scutellaria and its main active constituents wogonin, baicalein and baicalin. Cancer Treatment Reviews 35, 57-68.
28. Li, D., Wang, D., Wang, Y., Ling, W., Feng, X., Xia, M., 2010. Adenosine monophosphate-activated protein kinase induces cholesterol efflux from macrophage-derived foam cells and alleviates atherosclerosis in apolipoprotein E-deficient mice. Journal of Biological Chemistry 285, 33499-33509.
29. Liang, K.W., Ting, C.T., Yin, S.C., Chen, Y.T., Lin, S.J., Liao, J.K., Hsu, S.L., 2006. Berberine suppresses MEK/ERK-dependent Egr-1 signaling pathway and inhibits vascular smooth muscle cell regrowth after in vitro mechanical injury. Biochemistry and Pharmacology 71, 806-817.
30. Noh, B.K., Lee, J.K., Jun, H.J., Lee, J.H., Jia, Y., Hoang, M.H., Kim, J.W., Park, K.H., Lee, S.J., 2011. Restoration of autophagy by puerarin in ethanol-treated hepatocytes via the activation of AMP-activated protein kinase. Biochemical and Biophysical Research Communications 414, 361-366.
31. Park, E., Kum, S., Wang, C., Park, S.Y., Kim, B.S., Schuller-Levis, G., 2005. Anti-inflammatory activity of herbal medicines: inhibition of nitric oxide production and tumor necrosis factor-alpha secretion in an activated macrophage-like cell line. American Journal of Chinese Medicine 33, 415-424.
32. Peng, C.Y., Pan, S.L., Huang, Y.W., Guh, J.H., Chang, Y.L., Teng, C.M., 2008. Baicalein attenuates intimal hyperplasia after rat carotid balloon injury through arresting cell-cycle progression and inhibiting ERK, Akt, and NF-kappa B activity in vascular smooth-muscle cells. Naunyn-Schmiedeberg's Archives of Pharmacology 378, 579-588.
33. Rong, H., Stevens, J.F., Deinzer, M.L., Cooman, L.D., Keukeleire, D.D., 1998. Identification of isoflavones in the roots of Pueraria lobata. Planta Medica 64, 620-627.
34. Sarre, A., Gabrielli, J., Vial, G., Leverve, X.M., Assimacopoulos- Jeannet, F., 2012. Reactive oxygen species are produced at low glucose and contribute to the activation of AMPK in insulin-secreting cells. Free Radical Biology and Medicine 52, 142-150.
35. Schimmack, G., Defronzo, R.A., Musi, N., 2006. AMP-activated protein kinase: role in metabolism and therapeutic implications. Diabetes Obesity and Metabolism 8, 591-602.
36. Seglen, P.O., 1976. Preparation of isolated rat liver cells. Methods Biology 13, 29-83.
37. Sieveking, D.P., Woo, K.S., Fung, K.P., Lundman, P., Nakhla, S., Celermajer, D.S., 2005. Chinese herbs Danshen and Gegen modulate key early atherogenic events in vitro. International Journal of Cardiology 105, 40-45.
38. Sugawara, A., Uruno, A., Kudo, M., Matsuda, K., Yang, C.W., Ito, S., 2010. Effects of PPARγ on hypertension, atherosclerosis, and chronic kidney disease. Endocr Journal 57, 847-852.
39. Tang, S.Y., Whiteman, M., Peng, Z.F., Jenner, A., Yong, E.L., Halliwell, B., 2004. Characterization of antioxidant and antiglycation properties and isolation of active ingredients from traditional Chinese medicines. Free Radical Biology and Medicine 36, 1575-1587.
40. Tang, J., Feng, Y., Tsao, S., Wang, N., Curtain, R., Wang, Y., 2009. Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. Journal of Ethnopharmacology 126, 5-17.
41. Thomson, D.M., Winder, W.W., 2009. AMP-activated protein kinase control of fat metabolism in skeletal muscle. Acta Physiologica (Oxford) 196, 147-154.
42. Viollet, B., Guigas, B., Leclerc, J., Hébrard, S., Lantier, L., Mounier, R., Andreelli, F., Foretz, M., 2009. AMP-activated protein kinase in the regulation of hepatic energy metabolism: from physiology to therapeutic perspectives. Acta Physiologica 196, 81-98.
43. Wang, C.Y., Kao, T.C., Lo, W.H., Yen, G.C., 2011a. Glycyrrhizic acid and 18β-glycyrrhetinic acid modulate the lipopolysaccharide-induced inflammatory response by the suppression of NF-κB through PI3K p110δ and p110γ inhibitions. Journal of Agricultural and Food Chemistry 59, 7726-7733.
44. Wang, Q., Zhang, M., Liang, B., Shirwany, N., Zhu, Y., Zou, M.H., 2011b. Activation of AMP-activated protein kinase is required for berberine-induced reduction of atherosclerosis in mice: the role of uncoupling protein 2. PLoS One 6, e25436.
45. Wei, C.Y., Chou, Y.H., Ho, F.M., Hsieh, S.L., Lin, W.W., 2006. Signaling pathways of LIGHT induced macrophage migration and vascular smooth muscle cell proliferation. Journal of Cellular Physiology 209, 735-743.
46. Wei, S., Kulp, S.K., Chen, C.S., 2010. Energy restriction as an antitumor target of thiazolidinediones. Journal of Biological Chemistry 285, 9780-9791.
47. Woo, K.J., Lim, J.H., Suh, S.I., Kwon, Y.K., Shin, S.W., Kim, S.C., Choi, Y.H., Park, J.W., Kwon, T.K., 2006. Differential inhibitory effects of baicalein and baicalin on LPS-induced cyclooxygenase-2 expression through inhibition of C/EBPbeta DNA-binding activity. Immunobiology 211, 359-368.
48. Xia, X., Yan, J., Shen, Y., Tang, K., Yin, J., Zhang, Y., Yang, D., Liang, H., Ye, J., Weng, J., 2011. Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis. PLoS One 6, e16556.
49. Xie, Z., Dong, Y., Zhang, M., Cui, M.Z., Cohen, R.A., Riek, U., Neumann, D., Schlattner, U., Zou, M.H., 2006. Activation of protein kinase C zeta by peroxynitrite regulates LKB1-dependent AMP-activated protein kinase in cultured endothelial cells. Journal of Biological Chemistry 281, 6366-6375.
50. Xie, W., Gu, D., Li, J., Cui, K., Zhang, Y., 2011. Effects and action mechanisms of berberine and Rhizoma Coptidis on gut microbes and obesity in high-fat diet-fed C57BL/6J mice. PLoS One 6, e24520.
51. Xu, Q., Si, L.Y., 2010. Protective effects of AMP-activated protein kinase in the cardiovascular system. Journal of Cell Molecular Medicine 14. 2604-1263
52. Yan, L.P., Chan, S.W., Chan, A.S., Chen, S.L., Ma, X.J., Xu, H.X., 2006. Puerarin decreases serum total cholesterol and enhances thoracic aorta endothelial nitric oxide synthase expression in diet-induced hypercholesterolemic rats. Life Sciences 79, 324-330.
53. Ye, M., Fu, S., Pi, R., He, F., 2009. Neuropharmacological and pharmacokinetic properties of berberine: a review of recent research. Journal of Pharmacy and Pharmacology 61, 831-837.
54. Yeung, D.K., Leung, S.W., Xu, Y.C., Vanhoutte, P.M., Man, R.Y., 2006. Puerarin, an isoflavonoid derived from Radix puerariae, potentiates endothelium-independent relaxation via the cyclic AMP pathway in porcine coronary artery. European Journal of Pharmacology 552, 105-111.
55. Yoon, M.J., Lee, G.Y., Chung, J.J., Ahn, Y.H., Hong, S.H., Kim, J.B., 2006. Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase, p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55, 2562-2570.
56. Zhu, L.H., Wang, L., Wang, D., Jiang, H., Tang, Q.Z., Yan, L., Bian, Z.Y., Wang, X.A., Li, H., 2010. Puerarin attenuates high-glucose- and diabetes-induced vascular smooth muscle cell proliferation by blocking PKCbeta2/Rac1-dependent signaling. Free Radical Biology and Medicine 48, 471-482.